Join to view full profile
750 Welch RdSuite 315Palo Alto, CA 94304
Phone+1 650-497-8800
Fax+1 650-497-8612
Dr. Frymoyer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Adam Frymoyer is a Pediatrician based in Palo Alto, CA, specializing in Neonatology and serving as a Hospitalist. He obtained his medical degree from the University of Pittsburgh School of Medicine and had extensive training at the University of California, San Francisco, in Clinical Pharmacology, Pediatrics, and Pharmacometrics. He currently serves as a Clinical Associate Professor at Stanford University School of Medicine. He has a wealth of experience in pharmacology, clinical decision support systems, diseases in newborn infants, drug therapy, and pharmacokinetics. Dr. Frymoyer has contributed to the medical field with several publications and was involved in a clinical trial studying Oral Hymecromone and Hyaluronan Synthesis. His outstanding work earned him numerous recognitions, including the Early Career Investigator from Pediatric Research in 2017.
Education & Training
University of California (San Francisco)Fellowship, Pediatrics, 2011 - 2012- University of California San Francisco School of MedicinePost-Doctoral Fellowship, 2010 - 2011
- University of California (San Francisco) School of MedicineFellowship, Clinical Pharmacology, 2007 - 2010
- University of California (San Francisco)Residency, Pediatrics, 2004 - 2007
University of Pittsburgh School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2006 - 2028
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Early Career Investigator Pediatric Research, 2017
- Presidential Trainee Award American Society of Clinical Pharmacology and Therapeutics, 2010
- Elected Alpha Omega Alpha Honor Medical Society, 2003
Clinical Trials
- A Study of Oral Hymecromone and Hyaluronan Synthesis Start of enrollment: 2020 Dec 01
Publications & Presentations
PubMed
- A Decade Later: Serial Clinical Examinations for Early Onset Sepsis in Neonates of at Least 35 Weeks' Gestation.Adam Frymoyer, Arun Gupta, Juliann L Kim, Jessica M Allan, Janelle L Aby
Hospital Pediatrics. 2026-04-01 - 1 citationsHitting the Target: Model-Informed Precision Dosing of Tobramycin in Pediatric Patients with Cystic Fibrosis.Jake M Brockmeyer, Laura Bio, Carlos Milla, Adam Frymoyer
Pharmaceuticals. 2026-01-14 - 2 citationsImplementation of the VancomycIn per Pharmacy Education tRaining (VIPER) program for pharmacists at a children's hospital.Laura Bio, Shabnam Gaskari, Hayden T Schwenk, Jeffrey Moss, Adam Frymoyer
American Journal of Health-System Pharmacy. 2026-01-06
Journal Articles
- An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin‐Resist...Adam L Hersh, Adam Frymoyer, Jeffery T Zobell, The Journal of Clinical Pharmacology
Press Mentions
Improving Care of Newborns, One Baby at a TimeFebruary 27th, 2020
Professional Memberships
- Member
- Fellow
- American Society for Clinical Pharmacology and Therapeutics (ASCPT)Member
- American Society of Pharmacometrics (ASoP)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
